World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , 

World Journal of Pharmaceutical
and Medical Research

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301

ICV : 78.6



Dr. Sehar Sadaat*, Dr. Hira Ijaz, Dr. Noor Fatima Zahid, Dr. Amna Iqbal


Background: With increasing trends towards sedentary life style, obesity, diabetes mellitus, hypertension, and dyslipidaemia, the prevalence of metabolic syndrome (MetS) is rising in our country. In view of importance of diagnosis of MetS in day to day medical practice for early institution of life style therapies to reduce the atherosclerotic cardiovascular disease risk in susceptible population like in diabetes mellitus, this study has been undertaken to study the prevalence of metabolic syndrome in pakistani diabetes by applying National Cholesterol Education Programme/ Adult Treatment panel (NCEP/ATP) III and International Diabetes Federation (IDF) criteria. Methods: This is a hospital based cross sectional study conducted in diabetes patients aged between 25-75 years of age presenting to Allied Hospital, Faisalabad. Different components of MetS were studied in diabetes subjects and prevalence of metabolic syndrome was obtained by applying NCEP/ATP III and IDF criteria respectively. The data were collected as per preformed proforma and results analyzed by SPSS-16 software. Results: The prevalence of metabolic syndrome in diabetes patients as per NCEP/ATP III and IDF criteria were 71% and 82% respectively. A higher number of cases with metabolic syndrome were detected using IDF criteria as opposed to NCEP/ATP III criteria in diabetes patients. Pakistani diabetes subjects showed high prevalence of abdominal obesity followed by hypertension. Conclusions: The results of the present study show high prevalence of Mets in Pakistani diabetes patients and more number of cases can be diagnosed by applying IDF criteria as compared to NCEP/ATP III criteria.

[Full Text Article]

Powered By WJPMR | All Right Reserved